title: [Peptide growth factors in the prostate].
abstract: Growth and development of the prostate depend on androgen action and other factors. Androgens act directly by specific nuclear receptors and induce or control many effects mediated by peptide growth factors on both epithelial and stromal cells. The major important peptide growth factors detected in the prostate are Fibroblast Growth Factors, Transforming Growth Factors, and Epidermal Growth Factor. These factors are not prostate specific. They are produced by epithelial or stromal cells and regulate the growth of these two cell compartments through autocrine or paracrine pathways. Overproduction of these factors or modification in affinity or number of cell receptors may participate in the two main prostatic pathologies: benign hyperplasia or adenocarcinoma. Recently, other factors have been evidenced in the prostate: Interleukine 6, Nerve Growth Factor or Insulin-like Growth factors. The study of the localization and the effects of these factors may be crucial to understand the prostatic development and diseases and may suggest new targets for therapy.
authors.affiliation: Laboratoire de Pharmacologie Clinique et Expérimentale, Institut de Génétique Moléculaire, Paris, France.
authors.forename: R
authors.initials: R
authors.lastname: Tatoud
authors.forename: F
authors.initials: F
authors.lastname: Desgrandchamps
authors.forename: A
authors.initials: A
authors.lastname: DeGeorges
authors.forename: F
authors.initials: F
authors.lastname: Thomas
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000503:physiopathology; D004815:Epidermal Growth Factor / Q000502:physiology*; D005346:Fibroblast Growth Factors / Q000502:physiology*; D006801:Humans; D015850:Interleukin-6 / Q000502:physiology; D008297:Male; D009414:Nerve Growth Factors / Q000502:physiology; D011467:Prostate / Q000502:physiology*; D011470:Prostatic Hyperplasia / Q000503:physiopathology; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000503:physiopathology; D013498:Suramin / Q000627:therapeutic use; D016211:Transforming Growth Factor alpha / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000502:physiology*
chemical_list: D015850:Interleukin-6; D009414:Nerve Growth Factors; D016211:Transforming Growth Factor alpha; D016212:Transforming Growth Factor beta; D013498:Suramin; D005346:Fibroblast Growth Factors; D004815:Epidermal Growth Factor